JPM Interview: Pfizer, Allergan CEOs On Research, Deals, Drug Pricing And The Future

It seems like Pfizer Inc. CEO Ian Read and Allergan PLC CEO Brent Saunders are seldom seen apart these days as they meet with investors and reporters to discuss the finer points of their companies' pending $160bn merger, including at the 34th Annual JP Morgan Healthcare Conference in San Francisco where Scrip spoke with the chief executives about their views on early-stage research, drug pricing concerns and expectations for Pfizer's leadership in the future.